已收盘 07-02 16:00:00 美东时间
-0.590
-9.37%
今日重点评级关注:Ascendiant Capital:维持IGC Pharma"买入"评级,目标价从5.25美元升至5.5美元;Ascendiant Capital:维持Lucid Diagnostics"买入"评级,目标价从9美元升至9.25美元
06-09 11:33
Ascendiant Capital analyst Edward Woo maintains PAVmed (NASDAQ:PAVM) with a Buy and lowers the price target from $65 to $56.
06-08 18:08
PAVmed (NASDAQ:PAVM) reported first-quarter financial results on Friday. The tr...
05-15 22:11
PAVmed (NASDAQ:PAVM) reported quarterly losses of $(1.17) per share which missed the analyst consensus estimate of $(0.70) by 67.14 percent. This is a 44.29 percent increase over losses of $(2.10) per share from the same
05-15 20:01
Companies Reporting Before The Bell • Traws Pharma (NASDAQ:TRAW) is expected to...
05-15 19:11
Lucid Diagnostics Inc. (NASDAQ:LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (NASDAQ:PAVM), today announced the pricing of an
04-23 20:36
Medtech industry veteran to oversee development and commercialization of PAVmed's current and future medical device portfolio. Octeris, Inc. subsidiary formed to advance endoscopic esophagea...
04-02 20:01
Companies Reporting Before The Bell • Liberty All Star Equity (NYSE:USA) is est...
03-30 19:11
Gainers AstraZeneca PLC Ordinary Shares (NYSE:AZN) stock rose 107.1% to $192.1...
02-03 01:05
PAVmed shares pull back Thursday, possibly retracing recent gains on news its subsidiary, Lucid Diagnostics secured a contract
01-22 22:23